Yokubaitis and colleagues showed the neuroprotective effects of the combination of CBD and BCP in a mouse model of permanent ischemia, and Alonso and co-workers obtained superior results when both compounds were combined, in comparison to the single CBD and BCP administration in an in vitro model of cell inflammation, using LPS-stimulated BV2 cells [36,37]. Here, OPN1SW is linked to ischemia.